Atrium Therapeutics has successfully closed a $50 million private placement. The funding will support the company's ongoing development efforts.
Amount Raised
$50 Million
Round Type
Post-IPO Equity
San DiegoBiotechnologyHealth CareTherapeuticsDescription
Atrium Therapeutics has announced a robust funding event with the closing of a $50 million private placement. This capital will be directed towards advancing their therapeutic development projects. The funding reflects strong support and confidence in the company's future. Investors involved have shown commitment to Atrium's vision.
Quick answer
Atrium Therapeutics raised $50 Million in a Post-IPO Equity round, dated October 8, 2026. Atrium Therapeutics is based in San Diego, California, United States.
- How much did Atrium Therapeutics raise?
- Atrium Therapeutics raised $50 Million in a Post-IPO Equity round on October 8, 2026.
- What does Atrium Therapeutics do?
- Atrium Therapeutics, Inc. is a newly formed independent company resulting from the separation of Avidity Biosciences' early stage precision cardiology programs.
- Where is Atrium Therapeutics based and how big is it?
- Atrium Therapeutics is based in San Diego, California, United States. Fundz records about 11 employees.
- Who are the decision-makers at Atrium Therapeutics?
- Fundz holds 2 contacts at Atrium Therapeutics, including the Talent Acquisition. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Atrium Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
- VectorY raised $83M on November 11, 2026.
- Neurosterix raised $105M (Series B) on November 11, 2026.
- Oyster Therapeutics raised $60M (Series A) on November 10, 2026.
- SRTD biotech raised $35M (Seed) on November 9, 2026.
Who to call at Atrium Therapeutics, and when
A new round usually means Atrium Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Atrium Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Atrium Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Atrium Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Atrium Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Atrium Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.